Ovid Therapeutics Inc. Shareholders' Equity
Ovid Therapeutics Inc. (OVID) had Shareholders' Equity of $209.89 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $209.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $198.27M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $130.66M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $44.70M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $209.89M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $198.27M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $130.66M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $44.70M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $55.79M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $59.28M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $68.23M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $76.29M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $88.90M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $78.28M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $87.80M 10-K · filed 2026-03-18 | $87.80M 10-K · filed 2024-03-08 |
| 2023-09-30 | $101.29M 10-Q · filed 2024-11-12 | $101.29M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $110.70M 10-Q · filed 2024-11-12 | $110.70M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $120.95M 10-Q · filed 2024-11-12 | $120.95M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $132.27M 10-K · filed 2025-03-11 | $132.27M 10-K · filed 2023-03-13 |
| 2022-09-30 | $142.05M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $152.15M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $165.00M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $179.75M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $197.02M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $206.71M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $221.11M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $43.63M 10-K · filed 2023-03-13 | |
| 2020-09-30 | $63.64M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $30.48M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $51.44M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $70.02M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $30.05M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $45.44M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $57.25M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $38.81M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $49.97M 10-Q · filed 2019-11-08 | $49.97M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $61.12M 10-Q · filed 2019-11-08 | $61.12M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $72.09M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $83.44M 10-K · filed 2020-03-11 | |
| 2017-09-30 | $92.96M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $100.94M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $42.34M 10-Q · filed 2017-06-13 | |
| 2016-12-31 | $49.29M 10-K · filed 2019-03-07 | |
| 2015-12-31 | $68.07M 10-K · filed 2018-03-29 | |
| 2014-12-31 | $4.74M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |